Page last updated: 2024-09-03

celastrol and Diabetic Nephropathies

celastrol has been researched along with Diabetic Nephropathies in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Cai, BL; Huang, F; Lin, N; Mao, X; Su, XH; Wang, JR; Wang, KX; Wu, AG; Zhang, YG1
Cao, J; Lin, Y; Tang, X; Tang, Y; Wan, F; Yang, R; Zhang, H1
Fan, X; Fu, C; Hou, Z; Li, Y; Nie, Y; Tong, X; Xie, H; Yan, M; Zhang, H; Zhang, M1
Chen, Q; Chen, Y; Deng, L; Qiu, P; Wei, X; Xiao, J; Yan, C; Yang, Y; Zhan, X1
Chen, Y; Fan, XR; Nie, YS; Xie, H; Yan, M; Yang, MJ; Zhang, L; Zhang, M1

Other Studies

5 other study(ies) available for celastrol and Diabetic Nephropathies

ArticleYear
[In vitro "benefit-risk" evaluation and network regulation mechanism of Colquhounia Root Tablets and its key material basis].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2022, Volume: 47, Issue:23

    Topics: Animals; Arthritis, Rheumatoid; Cytokines; Diabetic Nephropathies; Drugs, Chinese Herbal; Glomerulonephritis, Membranous; Humans; Mice; Molecular Docking Simulation; Tablets

2022
Celastrol attenuates diabetic nephropathy by upregulating SIRT1-mediated inhibition of EZH2related wnt/β-catenin signaling.
    International immunopharmacology, 2023, Volume: 122

    Topics: Animals; beta Catenin; Diabetes Mellitus; Diabetic Nephropathies; Male; Mice; Podocytes; Proteinuria; Sirtuin 1; Wnt Signaling Pathway

2023
Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway.
    BMC complementary medicine and therapies, 2020, Oct-23, Volume: 20, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Kidney Glomerulus; Male; Molecular Structure; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Podocytes; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Streptozocin

2020
Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway.
    Molecular immunology, 2018, Volume: 104

    Topics: Animals; Autophagy; Cytokines; Diabetic Nephropathies; Gene Expression Regulation, Enzymologic; Glucose; Heme Oxygenase-1; Inflammation; Insulin Resistance; Membrane Proteins; Mice; Pentacyclic Triterpenes; Podocytes; Signal Transduction; Triterpenes

2018
Celastrol attenuates renal injury in diabetic rats via MAPK/NF-κB pathway.
    Phytotherapy research : PTR, 2019, Volume: 33, Issue:4

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Male; NF-kappa B; Pentacyclic Triterpenes; Rats; Rats, Sprague-Dawley; Transcription Factor RelA; Tripterygium; Triterpenes

2019